treprostinil
Sign in to saveAlso known as LRX-15, ({(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl}oxy)acetic acid, (1R,2R,3aS,9aS)-({2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl}oxy)acetic acid
Treprostinil, sold under the brand names Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation among others, is a vasodilator that is used for the treatment of pulmonary arterial hypertension.
Key facts
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 477864833
- Drug.image
- Treprostinil.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 250
- Drug.image2
- Treprostinil2.png
- Drug.image_class2
- bg-transparent
- Drug.tradename
- Remodulin, Orenitram, Tyvaso, others
- Drug.MedlinePlus
- a622038
- Drug.DailyMedID
- Treprostinil
- Drug.pregnancy_AU
- B3
- Drug.routes_of_administration
- Subcutaneous, intravenous, inhalation, by mouth
- Drug.ATC_prefix
- B01
- Drug.ATC_suffix
- AC21
- Drug.legal_US
- Rx-only
- Drug.legal_EU
- Rx-only
- Drug.legal_status
- Rx-only
via Wikipedia infobox
Research
987 papers- Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.The New England journal of medicine · 2021
- Treprostinil Use in the NICU.Advances in neonatal care : official journal of the National Association of Neonatal Nurses · 2024
- Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study.The Lancet. Respiratory medicine · 2021
- Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study.The European respiratory journal · 2023
- Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.Journal of the American College of Cardiology · 2010
via PubMed
Wikidata facts
- Mass
- 390.241
Show 5 more facts
- chemical formula
- C₂₃H₃₄O₅
- isomeric SMILES
- CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O
- canonical SMILES
- CCCCCC(CCC1C(CC2C1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O
- World Health Organisation international non-proprietary name
- treprostinil
- defined daily dose
- 4.3
via Wikidata · CC0
~3 min read
Article
7 sectionsContents
- Medical uses
- Adverse effects
- History
- Research
- References
- Further reading
- External links
Treprostinil, sold under the brand names Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation among others, is a vasodilator that is used for the treatment of pulmonary arterial hypertension.
Treprostinil was approved for use in the United States in May 2002.
Available in 16 languages
- Español
- Français
- Português
- العربية
- Bahasa Indonesia
- Nederlands
- Odia
- Polski
- Romanian
- Serbian
- Serbian (Latin)
- Telugu
- Türkçe
- Welsh
- فارسی
via Wikidata sitelinks · CC0